Accéder au contenu
Merck
  • Indispensable functions of ABL and PDGF receptor kinases in epithelial adherence of attaching/effacing pathogens under physiological conditions.

Indispensable functions of ABL and PDGF receptor kinases in epithelial adherence of attaching/effacing pathogens under physiological conditions.

American journal of physiology. Cell physiology (2014-05-23)
Carolin F Manthey, Christine B Calabio, Anna Wosinski, Elaine M Hanson, Bruce A Vallance, Alex Groisman, Martín G Martín, Jean Y J Wang, Lars Eckmann
RÉSUMÉ

Enteropathogenic Escherichia coli (EPEC) and Citrobacter rodentium are attaching-and-effacing (A/E) pathogens that cause intestinal inflammation and diarrhea. The bacteria adhere to the intestinal epithelium, destroy microvilli, and induce actin-filled membranous pedestals but do not invade the mucosa. Adherence leads to activation of several host cell kinases, including FYN, n-SRC, YES, ABL, and ARG, phosphorylation of the bacterial translocated intimin receptor, and actin polymerization and pedestal formation in cultured cells. However, marked functional redundancy appears to exist between kinases, and their physiological importance in A/E pathogen infections has remained unclear. To address this question, we employed a novel dynamic in vitro infection model that mimics transient and short-term interactions in the intestinal tract. Screening of a kinase inhibitor library and RNA interference experiments in vitro revealed that ABL and platelet-derived growth factor (PDGF) receptor (PDGFR) kinases, as well as p38 MAP kinase, have unique, indispensable roles in early attachment of EPEC to epithelial cells under dynamic infection conditions. Studies with mutant EPEC showed that the attachment functions of ABL and PDGFR were independent of the intimin receptor but required bacterial bundle-forming pili. Furthermore, inhibition of ABL and PDGFR with imatinib protected against infection of mice with modest loads of C. rodentium, whereas the kinases were dispensable for high inocula or late after infection. These results indicate that ABL and PDGFR have indispensable roles in early A/E pathogen attachment to intestinal epithelial cells and for in vivo infection with limiting inocula but are not required for late intimate bacterial attachment or high inoculum infections.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cycloheximide, from microbial, ≥94% (TLC)
Sigma-Aldrich
Cycloheximide solution, Ready-Made Solution, microbial, 100 mg/mL in DMSO, Suitable for cell culture
Sigma-Aldrich
Cycloheximide, ≥90% (HPLC)
Sigma-Aldrich
L-Threonine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%
Sigma-Aldrich
Cycloheximide, Biotechnology Performance Certified
SAFC
L-Threonine
Sigma-Aldrich
L-Threonine, reagent grade, ≥98% (HPLC)
Millipore
Cycloheximide solution, 0.1%, suitable for microbiology
Sigma-Aldrich
L-Threonine, BioXtra, ≥99.5% (NT)
L-Tyrosine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
DL-Tyrosine, 99%
Supelco
L-Threonine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Cycloheximide, PESTANAL®, analytical standard
Supelco
L-Threonine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mttp
L-Threonine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human MTTP
Sigma-Aldrich
MISSION® esiRNA, targeting human ABL1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Abl1
Sigma-Aldrich
MISSION® esiRNA, targeting human PDGFRB